InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,183.87
(
0.06%
)
US TECH 100
17,602.52
(
-0.04%
)
Dow Jones
38,862.32
(
0.03%
)
Brent Oil
83.16
(
-0.38%
)
Bitcoin
63,101.25
(
-0.10%
)
Post# of 6386
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rufus8421

Send PM Follow Ignore
Followers 2
Posts 71
Boards Moderated 0
Alias Born 12/29/2014

rufus8421

Re: ramad post# 4792

Wednesday, 09/28/2016 12:31:51 PM

Wednesday, September 28, 2016 12:31:51 PM

Post# of 6386
Yes, my theory is similar to yours although it may be only wishful thinking.
The recent management changes have been caused by an investor with deep pockets who sees the potential of ECTE. The amount of money needed to keep ECTE afloat is chump change to most pharmaceutical companies and the risk/reward ratio is attractive. It might also explain why ECTE and Scott Hollander in particular have ignored us because they knew they were short-timers.

If there is any merit to my theory, it will be reflected in the share price within the next couple of weeks.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up